N*1*-(3-Chloro-pyrazin-2-ylMethyl)-N*1*-cyclopropyl-ethane-1,2-diaMine
|
- $1694 - $1743
- Product name: N*1*-(3-Chloro-pyrazin-2-ylMethyl)-N*1*-cyclopropyl-ethane-1,2-diaMine
- CAS: 1353989-19-1
- MF: C10H15ClN4
- MW: 226.7059
- EINECS:
- MDL Number:MFCD21097488
- Synonyms:N*1*-(3-Chloro-pyrazin-2-ylMethyl)-N*1*-cyclopropyl-ethane-1,2-diaMine;N'-[(3-chloropyrazin-2-yl)methyl]-N'-cyclopropylethane-1,2-diamine
4 prices
Selected condition：
Brand
- Chemenu
- Crysdot
Package
- 1g
- ManufacturerChemenu
- Product numberCM334957
- Product descriptionN1-((3-Chloropyrazin-2-yl)methyl)-N1-cyclopropylethane-1,2-diamine 95%+
- Packaging1g
- Price$1694
- Updated2026-05-26
- Buy
- ManufacturerChemenu
- Product numberCM334957
- Product descriptionN1-((3-Chloropyrazin-2-yl)methyl)-N1-cyclopropylethane-1,2-diamine 95%+
- Packaging1g
- Price$1694
- Updated2026-05-20
- Buy
- ManufacturerChemenu
- Product numberCM334957
- Product descriptionN1-((3-Chloropyrazin-2-yl)methyl)-N1-cyclopropylethane-1,2-diamine 95%+
- Packaging1g
- Price$1743
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11284301
- Product descriptionN1-((3-Chloropyrazin-2-yl)methyl)-N1-cyclopropylethane-1,2-diamine 97%
- Packaging1g
- Price$1696
- Updated2026-05-26
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Chemenu | CM334957 | N1-((3-Chloropyrazin-2-yl)methyl)-N1-cyclopropylethane-1,2-diamine 95%+ | 1g | $1694 | 2026-05-26 | Buy |
| Chemenu | CM334957 | N1-((3-Chloropyrazin-2-yl)methyl)-N1-cyclopropylethane-1,2-diamine 95%+ | 1g | $1694 | 2026-05-20 | Buy |
| Chemenu | CM334957 | N1-((3-Chloropyrazin-2-yl)methyl)-N1-cyclopropylethane-1,2-diamine 95%+ | 1g | $1743 | 2021-12-16 | Buy |
| Crysdot | CD11284301 | N1-((3-Chloropyrazin-2-yl)methyl)-N1-cyclopropylethane-1,2-diamine 97% | 1g | $1696 | 2026-05-26 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|